In 2020, Jennifer Doudna won the Nobel Prize in chemistry for her work on the CRISPR-Cas9 gene-editing technology that allows ...

A signaling system known as the Wnt pathway plays a central role in how cells in the intestine grow, divide and renew ...

A new drug targets RAS cancer-causing cells in the pancreas, nearly doubling survival rates in clinical trials. Here's how ...

For roughly four decades, oncologists had a grim shorthand for the most common genetic driver of pancreatic cancer: ...

Researchers discovered that mutations linked to blood cancers may help trigger Alzheimer’s disease by creating overly ...

Researchers at the University of Oslo and Oslo University Hospital have developed a promising new immunotherapy targeting the CTNNB1 gene mutation associated with various aggressive cancers such as ...

A new daily pill called daraxonrasib is showing promise against advanced pancreatic cancer in a first-in-human trial of 168 ...

The discovery of a drug called daraxonrasib, which a Florida doctor was part of, could have implications for extending ...

Dr. Marwan G. Fakih explains that KRAS mutations, found in 45% of patients with colorectal cancer, include the rare KRAS G12C mutation, leading to Lumakras approval. According to the National Cancer ...

Sperm from a single donor in Europe has reportedly been used to conceive at least 67 pregnancies, although the donor carried a rare cancer-causing mutation. The donor’s mutation has been linked to ...

By Deena Beasley June 3 (Reuters) - Cathy Smithwick, now 67, has lived with breast cancer, and then ovarian cancer, for more ...

Although cancer treatments are improving fast, prevention has so far been mostly about promoting a healthy lifestyle. But ...